RecruitingPhase 1Phase 2NCT06532253
Long-term Safety Trial with NVDX3
Long-term Safety Bucket Trial with NVDX3, an Osteogenic Implant of Human Allogenic Origin.
Sponsor
Novadip Biosciences
Enrollment
15 participants
Start Date
Aug 22, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
An study evaluating the long-term safety of all patients previously treated with NVDX3.
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Patient being implanted with NVDX3.
- Previously participated to one of the NVDX3 core clinical trials.
- Patient accepts to comply to a yearly follow-up safety visit for 10 additional years
- Patient has understood and accepted to participate in the long-term follow-up study by signing the informed consent.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGNVDX3
NVDX3 is implanted during a single surgical intervention, that took place in the core trials (refer to NCT05961956 and NCT05987033)
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06532253
Related Trials
Topical TRanexamic Acid vs. Placebo on Acute Postoperative Pain Following DRF Fixation
NCT063844561 location
Prednisone for CRPS in Distal Radius Fracture
NCT064534471 location
Comparative Study Between Cannulated Screws and K-wires in the Fixation of Distal Radius Fractures
NCT075233861 location
Supraclavicular Bupivacaine Vs. Supraclavicular Liposomal Bupivacaine for Orthopedic Wrist Surgery
NCT061790041 location
Impact of Early ADL Education on Outcomes Post DRF ORIF
NCT062512061 location